Transpire Bio
Phase 1We aim to improve outcomes for diseases and conditions with unmet needs by applying our deep expertise and patented inhalation formulation and delivery platforms to drugs with a known mechanism of action, unlocking value through the creation of therapies designed to improve effectiveness or tolerability.
Founded
2021
Focus
Drug Delivery
About
We aim to improve outcomes for diseases and conditions with unmet needs by applying our deep expertise and patented inhalation formulation and delivery platforms to drugs with a known mechanism of action, unlocking value through the creation of therapies designed to improve effectiveness or tolerability.
Funding History
1Total raised: $40M
Series A$40MOrbiMedJan 15, 2023
Company Info
TypePrivate
Founded2021
LocationSan Diego, United States
StagePhase 1
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile